6.
Kim J, Jo H, Ha M, Kim H, Lee J, Han J
. Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea. Sci Rep. 2023; 13(1):8323.
PMC: 10205754.
DOI: 10.1038/s41598-023-33476-6.
View
7.
Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H, Fan Y
. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. J Transl Med. 2021; 19(1):58.
PMC: 8045209.
DOI: 10.1186/s12967-021-02705-9.
View
8.
Deng S, Zhu L, Huang D
. Predicting Hub Genes Associated with Cervical Cancer through Gene Co-Expression Networks. IEEE/ACM Trans Comput Biol Bioinform. 2015; 13(1):27-35.
DOI: 10.1109/TCBB.2015.2476790.
View
9.
Xu M, Zhang R, Qiu J
. A four immune-related long noncoding RNAs signature as predictors for cervical cancer. Hum Cell. 2021; 35(1):348-359.
DOI: 10.1007/s13577-021-00654-5.
View
10.
Xu W, Xu M, Wang L, Zhou W, Xiang R, Shi Y
. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduct Target Ther. 2019; 4:55.
PMC: 6908647.
DOI: 10.1038/s41392-019-0081-6.
View
11.
de Geus V, Ewing-Graham P, de Koning W, de Koning M, van den Bosch T, Nigg A
. Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis. Front Oncol. 2022; 11:715077.
PMC: 8787153.
DOI: 10.3389/fonc.2021.715077.
View
12.
Taarnhoj G, Christensen I, Lajer H, Fuglsang K, Jeppesen M, Kahr H
. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study. Cancer. 2017; 124(5):943-951.
DOI: 10.1002/cncr.31165.
View
13.
Geeitha S, Thangamani M
. Incorporating EBO-HSIC with SVM for Gene Selection Associated with Cervical Cancer Classification. J Med Syst. 2018; 42(11):225.
DOI: 10.1007/s10916-018-1092-5.
View
14.
Sample K
. DNA repair gene expression is associated with differential prognosis between HPV16 and HPV18 positive cervical cancer patients following radiation therapy. Sci Rep. 2020; 10(1):2774.
PMC: 7026103.
DOI: 10.1038/s41598-020-59383-8.
View
15.
Ijaz M, Attique M, Son Y
. Data-Driven Cervical Cancer Prediction Model with Outlier Detection and Over-Sampling Methods. Sensors (Basel). 2020; 20(10).
PMC: 7284557.
DOI: 10.3390/s20102809.
View
16.
Peiretti M, Zapardiel I, Zanagnolo V, Landoni F, Morrow C, Maggioni A
. Management of recurrent cervical cancer: a review of the literature. Surg Oncol. 2012; 21(2):e59-66.
DOI: 10.1016/j.suronc.2011.12.008.
View
17.
Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P
. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination. Tumori. 2023; 110(2):139-145.
DOI: 10.1177/03008916231208344.
View
18.
DOria O, Bogani G, Cuccu I, Golia DAuge T, Di Donato V, Caserta D
. Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature. Expert Opin Pharmacother. 2023; 25(1):55-65.
DOI: 10.1080/14656566.2023.2298329.
View
19.
Zhou L, Qiu Q, Zhou Q, Li J, Yu M, Li K
. Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer. Nat Commun. 2022; 13(1):2563.
PMC: 9091225.
DOI: 10.1038/s41467-022-30190-1.
View
20.
Li J, Liu G, Luo J, Yan S, Ye P, Wang J
. Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study. Sci Rep. 2022; 12(1):13994.
PMC: 9385852.
DOI: 10.1038/s41598-022-17733-8.
View